Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,847.45INR
12 Feb 2016
Change (% chg)

Rs-37.90 (-1.31%)
Prev Close
Rs2,885.35
Open
Rs2,914.90
Day's High
Rs2,934.15
Day's Low
Rs2,825.30
Volume
508,339
Avg. Vol
669,079
52-wk High
Rs4,386.60
52-wk Low
Rs2,750.05

REDY.NS

Chart for REDY.NS

About

Dr. Reddy's Laboratories Limited is an integrated global pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Global Generics segment consists of its business of manufacturing and... (more)

Overall

Beta: 0.44
Market Cap(Mil.): Rs485,591.41
Shares Outstanding(Mil.): 170.54
Dividend: 20.00
Yield (%): 0.70

Financials

  REDY.NS Industry Sector
P/E (TTM): 138.44 30.46 37.46
EPS (TTM): 20.57 -- --
ROI: -- 14.83 14.17
ROE: -- 15.40 14.92
Search Stocks

MEDIA-Torrent Pharma, Dr. Reddy's, Aurobindo, Cipla, Lupin in race to buy Sagent Pharma - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy (Bengaluru newsroom)

25 Jan 2016

BUZZ-India's Dr. Reddy's rises on Nexium generic relaunch in U.S.

** Dr. Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, rises as much as 2.31 pct to its highest level since Dec 7

30 Dec 2015

BUZZ-India's Dr Reddy's slumps; US FDA releases details of warning letter

** US FDA releases details of warning letter (http://1.usa.gov/1QIDDeg)

26 Nov 2015

BUZZ-India's Dr Reddy's says adheres to all disclosure norms; stock recovers

** Dr Reddy's Laboratories' shares recover to trade 1 pct lower after falling as much as 6.8 pct intraday

19 Nov 2015

BUZZ-Indian drug makers attract short positions despite being oversold

** Indian drug makers attract short positions in derivatives even after being oversold

10 Nov 2015

BUZZ-Indian drug makers slump; US FDA scrutiny, weak earnings weigh

** Sun Pharmaceutical Industries slumps 5.3 pct, Dr.Reddy's Laboratories down 1.7 pct and Lupin falls 1.6 pct

09 Nov 2015

BUZZ-India's Dr.Reddy's slumps after US FDA warning letter

** Says API manufacturing facilities at including Srikakulam and Oncology formulation facility at Duvvada in Andhra Pradesh gets a warning letter from US FDA

06 Nov 2015

BUZZ-India's Dr.Reddy's falls; rival Torrent Pharma gets approval for key drug

** Rival Torrent Pharmaceuticals Ltd TORP.NS> gains 3.6 pct; gets U.S. FDA approval for generic version of AstraZeneca Plc's heartburn pill Nexium - U.S. FDA website

21 Oct 2015

Earnings vs. Estimates

Search Stocks